Prevalence of lymphoreticular prion protein accumulation in UK tissue samples
Top Cited Papers
- 21 May 2004
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 203 (3), 733-739
- https://doi.org/10.1002/path.1580
Abstract
This study aims to provide an estimate of the number of individuals in the UK who may be incubating variant Creutzfeldt‐Jakob disease and at risk of causing iatrogenic spread of the disease. Lymphoreticular accumulation of prion protein is a consistent feature of variant Creutzfeldt‐Jakob at autopsy and has also been demonstrated in the pre‐clinical phase. Immunohistochemical accumulation of prion protein in the lymphoreticular system remains the only technique that has been shown to predict neurological disease reliably in animal prion disorders. In this study, immunohistochemistry was used to demonstrate the presence of prion protein, with monoclonal antibodies KG9 and 3F4, in surgically removed tonsillectomy and appendicectomy specimens. The samples were collected from histopathology departments across the UK and anonymised prior to testing. Samples were tested from 16 703 patients (14 964 appendectomies, 1739 tonsillectomies), approximately 60% of whom were from the age group 20–29 years at operation. Twenty‐five per cent of the samples were excluded from the final analyses because they contained inadequate amounts of lymphoid tissue. Three appendicectomy samples showed lymphoreticular accumulation of prion protein, giving an estimated prevalence of 3/12 674 or 237 per million (95% CI 49–692 per million). The pattern of lymphoreticular accumulation in two of these samples was dissimilar from that seen in known cases of variant Creutzfeldt‐Jakob disease. Although it is uncertain whether immunohistochemical accumulation of prion protein in the lymphoreticular system is specific for variant Creutzfeldt‐Jakob disease, it has not been described in any other disease, including other forms of human prion disease or a range of inflammatory and infective conditions. These findings reinforce the importance of measures taken by the UK Department of Health to reduce the risk of spread of variant Creutzfeldt‐Jakob via blood products and surgical instruments, and of the urgency to proceed with large‐scale screening of fresh tonsil specimens for the presence of prion protein. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 49 references indexed in Scilit:
- Creutzfeldt–Jakob disease and inclusion body myositis: Abundant disease‐associated prion protein in muscleAnnals of Neurology, 2003
- Possible underascertainment of variant Creutzfeldt-Jakob disease: a systematic studyJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Predictability of the UK Variant Creutzfeldt-Jakob Disease EpidemicScience, 2001
- Long-Term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in HumansJournal of Virology, 2001
- vCJD – predicting the future?Neuropathology and Applied Neurobiology, 2000
- Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjectsAnnals of Neurology, 1999
- Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samplesThe Lancet, 1999
- A new variant of Creutzfeldt-Jakob disease in the UKThe Lancet, 1996
- Decontamination studies with the agents of bovine spongiform encephalopathy and scrapieArchiv für die gesamte Virusforschung, 1994
- Pathogenesis of scrapie in mice after intragastric infectionVirus Research, 1989